Hester Biosciences Limited

BSE:524669 Stock Report

Market Cap: ₹20.4b

Hester Biosciences Management

Management criteria checks 3/4

Hester Biosciences' CEO is Rajiv Gandhi, appointed in Mar 2005, has a tenure of 19.75 years. total yearly compensation is ₹37.07M, comprised of 51.4% salary and 48.6% bonuses, including company stock and options. directly owns 10.47% of the company’s shares, worth ₹2.13B. The average tenure of the management team and the board of directors is 6.6 years and 4.7 years respectively.

Key information

Rajiv Gandhi

Chief executive officer

₹37.1m

Total compensation

CEO salary percentage51.4%
CEO tenure19.8yrs
CEO ownership10.5%
Management average tenure6.6yrs
Board average tenure4.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Rajiv Gandhi's remuneration changed compared to Hester Biosciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹235m

Jun 30 2024n/an/a

₹194m

Mar 31 2024₹37m₹19m

₹189m

Dec 31 2023n/an/a

₹185m

Sep 30 2023n/an/a

₹257m

Jun 30 2023n/an/a

₹285m

Mar 31 2023₹41m₹19m

₹266m

Dec 31 2022n/an/a

₹298m

Sep 30 2022n/an/a

₹271m

Jun 30 2022n/an/a

₹308m

Mar 31 2022₹48m₹20m

₹393m

Dec 31 2021n/an/a

₹413m

Sep 30 2021n/an/a

₹451m

Jun 30 2021n/an/a

₹412m

Mar 31 2021₹52mn/a

₹344m

Dec 31 2020n/an/a

₹275m

Sep 30 2020n/an/a

₹267m

Jun 30 2020n/an/a

₹265m

Mar 31 2020₹39mn/a

₹292m

Dec 31 2019n/an/a

₹396m

Sep 30 2019n/an/a

₹409m

Jun 30 2019n/an/a

₹413m

Mar 31 2019₹21m₹20m

₹416m

Mar 31 2018₹24m₹19m

₹256m

Compensation vs Market: Rajiv's total compensation ($USD433.64K) is above average for companies of similar size in the Indian market ($USD181.62K).

Compensation vs Earnings: Rajiv's compensation has been consistent with company performance over the past year.

CEO

Rajiv Gandhi (62 yo)

19.8yrs

Tenure

₹37,070,000

Compensation

Mr. Rajiv Dinesh Gandhi serves as Independent Director for Steelcast Limited since January 23, 2023. Mr. Gandhi joined the Steelcast Limited on January 23, 2023. He has been the Executive Chief Executive O...

Leadership Team

NamePositionTenureCompensationOwnership
Rajiv Gandhi
Executive CEO19.8yrs₹37.07m10.47%
₹ 2.1b
Priya Gandhi
Executive Directorno data₹5.40mno data
Divyesh Maru
Chief Financial Officerless than a yearno datano data
Vinod Mali
Company Secretary & Compliance Officer6.6yrsno datano data
Sulochana Shrestha
CEO of Hester Biosciences Nepal Private Limitedno datano datano data
Upendra Jani
Consultantno datano datano data

6.6yrs

Average Tenure

62yo

Average Age

Experienced Management: 524669's management team is seasoned and experienced (6.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Rajiv Gandhi
Executive CEO37.7yrs₹37.07m10.47%
₹ 2.1b
Priya Gandhi
Executive Director3.2yrs₹5.40mno data
Bhupendra Gandhi
Non-Executive Non-Independent Chairman32yrs₹250.00k4.69%
₹ 956.3m
Ravin Gandhi
Non-Executive & Non-Independent Director25.7yrsno data4.74%
₹ 966.4m
Sanjiv Gandhi
Non Executive Non Independent Director37.7yrs₹270.00k8.2%
₹ 1.7b
Ameet kumar Desai
Non-Executive Independent Director3.2yrs₹150.00kno data
Nina Gandhi
Alternate Director8.6yrs₹150.00k8.19%
₹ 1.7b
Ashok Bhadakal
Non-Executive Independent Director4.7yrs₹480.00kno data
Sandhya Patel
Non-Executive Independent Director4.7yrs₹500.00kno data
Jatin Trivedi
Non-Executive & Independent Director1.5yrs₹150.00kno data
Anil Jain
Non-Executive & Independent Director1.5yrs₹100.00kno data

4.7yrs

Average Tenure

58.5yo

Average Age

Experienced Board: 524669's board of directors are considered experienced (4.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 13:32
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hester Biosciences Limited is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vaishali Kumar ParkarBOB Capital Markets Ltd.
Kameswari V. S. ChavaliFirstCall Research
Siddhant KhandekarICICIdirect.com